Lastly, cells from the combination therapy PD-1+SMI group were mainly clustered in the apoptotic branch (NNMT+ and FSTL1+ tumor cells), suggesting that PD-1 inhibitor combined with SMI induces tumor apoptosis. This evidence concerns the gene PDCD1 and neoplasm.